Abstract:Microphthalmia (MITF) gene product, a transcription factor of the basic-helix-loop-helix type, is thought to play a role in the regulation of genes encoding the enzymes necessary for melanogenesis. These include tyrosinase, TRP-1 and TRP-2. Melanocyte-specific isoform of microphthalmia, MITF-M, is expressed in normal and malignant melanocytes. The presence of two other isoforms of microphthalmia, MITF-A and MITF-H, which differ from MITF-M in the amino-terminus, was demonstrated also in some non-melanocytic lineages. Here we have analyzed the presence of all three known isoforms of MITF mRNA in a panel of 17 human melanoma cell lines by a reverse transcriptase-polymerase chain reaction using isoform-specific primers. While, as expected, the predominant form in melanoma cell lines was MITF-M, low amounts of MITF-A mRNA was found in almost all melanomas, as well as in most of 20 tumor cell lines of the non-melanocyte origin (lung and colon carcinomas, osteosarcomas and neuroblastomas). The expression of MITF-H was not detected, with a few exceptions, in the tested cell lines. Pax3 transcription factor was reported earlier to regulate positively the melanocyte-specific promoter of the MITF gene. We found here that the Pax 3 mRNA was expressed in all melanoma cell lines, even in those that had repressed the MITF-M and were amelanotic. This suggests that additional factors, besides Pax3, are required for the MITF expression. The MSG1 (melanocyte-specific gene 1), a gene originally isolated from melanocytes and containing a strong transcription activation domain, was also found expressed in all melanomas and most non-melanocyte tumor cell lines. Together, these data indicate that the MITF-M isoform is the major type of MITF mRNA present in human melanoma cell lines and show that the expression of the isoform MITF-A and the MSG1 is not restricted to malignant melanocytes and occurs in a wide range of tumor cell lines.

Generation and expression of recombinant eukaryotic expression plasmids of MITF gene and its significance

Study of Gene Mutation and Pathogenetic Mechanism for a Family with Waardenburg Syndrome

Experimental Studies on Regulation of PAX3 on Transcriptional Activities of Target Gene MITF

Wnt Signaling Pathway Involvement in Genotypic and Phenotypic Variations in Waardenburg Syndrome Type 2 with MITF Mutations

Molecular pathogenesis of Waardenburg syndrome type Ⅱ resulting from SOX10 gene mutation

MITF: A Stream Flowing for Pigment Cells

A Homozygous MITF Mutation Leads to Familial Waardenburg Syndrome Type 4

Mitf-Mdel, a Novel Melanocyte/melanoma-Specific Isoform of Microphthalmia-Associated Transcription Factor-M, As a Candidate Biomarker for Melanoma

Expression and Significance of MITF-M Transcripts in Clear Cell Sarcoma of Soft Tissue

Lipocalin-type Prostaglandin D Synthase As a Melanocyte Marker Regulated by MITF.

Deubiquitination of MITF-M Regulates Melanocytes Proliferation and Apoptosis

MITF: master regulator of melanocyte development and melanoma oncogene

Identification of A Novel Missense Mutation of Mip in A Chinese Family with Congenital Cataracts by Target Region Capture Sequencing

MITF in melanoma: mechanisms behind its expression and activity

Microphthalmia-Associated Transcription Factor (MITF): Multiplicity in Structure, Function, and Regulation

Novel mechanisms of MITF regulation identified in a mouse suppressor screen

Double heterozygous mutations of MITF and PAX3 result in Waardenburg syndrome with increased penetrance in pigmentary defects

A unique hyperdynamic dimer interface permits small molecule perturbation of the melanoma oncoprotein MITF for melanoma therapy

Novel Gene Fusion of PRCC-MITF Defines a New Member of MiT Family Translocation Renal Cell Carcinoma: Clinicopathological Analysis and Detection of the Gene Fusion by RNA Sequencing and FISH.

Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas

In Vivo Role of Alternative Splicing and Serine Phosphorylation of the Microphthalmia-Associated Transcription Factor